Markets saw a volatile session with Nifty trading below the 23,800-24,000 resistance zone, though select heavyweight buying limited downside. Several companies like ITC, Nykaa, and IndusInd Bank are in focus due to Q4 results and news developments, including Lenskart's profit decline and Dr. Reddy's new diabetes drug launch.

Indian equity markets ended last week under pressure, with benchmark indices struggling to hold gains due to weak technical indicators and selling in heavyweight stocks. Analyst…

Indian indices were subdued with Nifty up 0.03% and Sensex down 0.10%. High volatility (VIX at 19.63) and bearish momentum indicators suggest near-term weakness. Analysts expect…

Indian markets saw a volatile Monday, ending nearly flat due to global weakness and economic worries. Analysts suggest Nifty is consolidating, with resistance at 23,800-24,000 and…

Equity benchmark indices Sensex and Nifty ended lower on Tuesday after a late-session sell-off in heavyweight stocks such as HDFC Bank and Reliance Industries erased early gains,…

Domestic equities closed marginally lower due to weakness in financial and consumer shares, despite gains in IT stocks. Analysts suggest the short-term sentiment remains bearish,…

Indian markets navigated a sideways trend, with analysts urging caution until the 24,000 mark is reclaimed. Key stocks like Lenskart, Apollo Hospitals, ZEE, BPCL, and Hindalco are…

Markets saw a volatile session with Nifty trading below the 23,800-24,000 resistance zone, though select heavyweight buying limited downside. Several companies like ITC, Nykaa,…

Indian stock markets closed lower in volatile trading, with the BSE Sensex and NSE Nifty both surrendering earlier gains.